Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial.
J Allergy Clin Immunol. 2021 Sep;148(3):790-798. doi: 10.1016/j.jaci.2021.03.044. Epub 2021 Apr 16.
J Allergy Clin Immunol. 2021.
PMID: 33872652
Free article.
Clinical Trial.